People who lose their sense of smell have far fewer treatment options than those who have lost other senses, like hearing or vision. But Columbia experts are developing new therapies and resources.
Pathologists Dan Green, MD, and Stephen Lagana, MD, sat down with us to explain their jobs, describe their training, and share the most fascinating cases of their careers.
Recently, AI was used by research scientists to help detect pancreatic cancer three years faster than could be done without the technology. Pancreatic Cancer expert John Chabot, MD explains.
Neil Shneider, MD, PhD, discusses how patients have fared in the phase three trial of tofersen and how the drug will impact ALS treatment in the future.
Columbia’s cell therapy lab, which creates customized cell therapies, is testing its first product, T cells trained to fight dangerous infections in transplant patients.